Corvus Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Jan 27, 2026
Filed with the SEC on Jan 27, 2026 and accepted by EDGAR at Jan 27, 2026, 20:38 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000947871-26-000068. Last ingested by Listed: Nov 15, 2026, 00:49 ET. Listed shows no prices and gives no investment advice.